These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8152913)

  • 1. Endogenous viral complexes with long RNA cosediment with the agent of Creutzfeldt-Jakob disease.
    Akowitz A; Sklaviadis T; Manuelidis L
    Nucleic Acids Res; 1994 Mar; 22(6):1101-7. PubMed ID: 8152913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protected endogenous retroviral sequences copurify with infectivity in experimental Creutzfeldt-Jakob disease.
    Akowitz A; Manuelidis EE; Manuelidis L
    Arch Virol; 1993; 130(3-4):301-16. PubMed ID: 8517790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential retroviral RNAs in Creutzfeldt-Jakob disease.
    Murdoch GH; Sklaviadis T; Manuelidis EE; Manuelidis L
    J Virol; 1990 Apr; 64(4):1477-86. PubMed ID: 2108258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral particles are required for infection in neurodegenerative Creutzfeldt-Jakob disease.
    Manuelidis L; Sklaviadis T; Akowitz A; Fritch W
    Proc Natl Acad Sci U S A; 1995 May; 92(11):5124-8. PubMed ID: 7761460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dementias, neurodegeneration, and viral mechanisms of disease from the perspective of human transmissible encephalopathies.
    Manuelidis L
    Ann N Y Acad Sci; 1994 Jun; 724():259-81. PubMed ID: 8030947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualization of viral candidate cDNAs in infectious brain fractions from Creutzfeldt-Jakob disease by representational difference analysis.
    Dron M; Manuelidis L
    J Neurovirol; 1996 Aug; 2(4):240-8. PubMed ID: 8799215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleic acid binding proteins in highly purified Creutzfeldt-Jakob disease preparations.
    Sklaviadis T; Akowitz A; Manuelidis EE; Manuelidis L
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5713-7. PubMed ID: 8516321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological analysis of host and agent effects on Creutzfeldt-Jakob disease and scrapie prion proteins.
    Bockman JM; Kingsbury DT
    J Virol; 1988 Sep; 62(9):3120-7. PubMed ID: 2900341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scrapie and Creutzfeldt-Jakob disease prion proteins share physical properties and antigenic determinants.
    Bendheim PE; Bockman JM; McKinley MP; Kingsbury DT; Prusiner SB
    Proc Natl Acad Sci U S A; 1985 Feb; 82(4):997-1001. PubMed ID: 2579394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclease treatment results in high specific purification of Creutzfeldt-Jakob disease infectivity with a density characteristic of nucleic acid-protein complexes.
    Sklaviadis T; Akowitz A; Manuelidis EE; Manuelidis L
    Arch Virol; 1990; 112(3-4):215-28. PubMed ID: 1974131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclease-resistant polyadenylated RNAs of significant size are detected by PCR in highly purified Creutzfeldt-Jakob disease preparations.
    Akowitz A; Sklaviadis T; Manuelidis EE; Manuelidis L
    Microb Pathog; 1990 Jul; 9(1):33-45. PubMed ID: 1706452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biology of type A endogenous retrovirus.
    Ono M
    Kitasato Arch Exp Med; 1990 Sep; 63(2-3):77-90. PubMed ID: 1710682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prions--infectious pathogens causing the spongiform encephalopathies.
    Prusiner SB; Kingsbury DT
    CRC Crit Rev Clin Neurobiol; 1985; 1(3):181-200. PubMed ID: 3915974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Creutzfeldt-Jakob disease infectious fractions by gel permeation chromatography and sedimentation field flow fractionation.
    Sklaviadis T; Dreyer R; Manuelidis L
    Virus Res; 1992 Dec; 26(3):241-54. PubMed ID: 1492497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scrapie-associated precursor proteins: antigenic relationship between species and immunocytochemical localization in normal, scrapie, and Creutzfeldt-Jakob disease brains.
    Safar J; Ceroni M; Piccardo P; Gajdusek DC; Gibbs CJ
    Neurology; 1990 Mar; 40(3 Pt 1):513-7. PubMed ID: 1969126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific proteins associated with Creutzfeldt-Jakob disease and scrapie share antigenic and carbohydrate determinants.
    Manuelidis L; Valley S; Manuelidis EE
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4263-7. PubMed ID: 2408277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of major peptides in Creutzfeldt-Jakob disease and scrapie.
    Sklaviadis T; Manuelidis L; Manuelidis EE
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6146-50. PubMed ID: 3090551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoblotting of Creutzfeldt-Jakob disease prion proteins: host species-specific epitopes.
    Bockman JM; Prusiner SB; Tateishi J; Kingsbury DT
    Ann Neurol; 1987 Jun; 21(6):589-95. PubMed ID: 3300520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease.
    Palmer MS; Dryden AJ; Hughes JT; Collinge J
    Nature; 1991 Jul; 352(6333):340-2. PubMed ID: 1677164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safe method for isolation of prion protein and diagnosis of Creutzfeldt-Jakob disease.
    Bastian FO; McDermott ME; Perry AS; Carver LA; Dash S; Garry RF
    J Virol Methods; 2005 Dec; 130(1-2):133-9. PubMed ID: 16102852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.